JLK, founded in 2014 and headquartered in South Korea, is a pioneering company in the AI sector, specializing in medical and security solutions. Recognized as one of the most highly funded AI startups in the region, the company embodies its slogan, "Leading the AI Industry with Data and AI Technology."
JLK's flagship product, AIHuB, supports the diagnosis of 37 diseases across 14 body parts, effectively integrating with existing imaging diagnostic systems. This innovation highlights their commitment to enhancing healthcare with cutting-edge AI technology. In addition, JLK's AI security solution offers robust protection by automatically detecting dangerous objects, ensuring public safety and safeguarding corporate intelligence.
The company has garnered substantial support from investors, having last received a KRW10.00B Venture Round investment on 07 March 2018 from prominent firms like InterVest Co., KB Investments, BNH Investment, SL Investment, and Medici Investment. The backing of these investors underscores JLK's potential for growth and innovation in the thriving AI industry.